Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Fredrick A. Moore is active.

Publication


Featured researches published by Fredrick A. Moore.


Molecular & Cellular Proteomics | 2006

High Dynamic Range Characterization of the Trauma Patient Plasma Proteome

Tao Liu; Wei Jun Qiant; Marina A. Gritsenko; Wenzhong Xiao; Lyle L. Moldawer; Amit Kaushal; Matthew E. Monroe; Susan M. Varnum; Ronald J. Moore; Samuel O. Purvine; Ronald V. Maier; Ronald W. Davis; Ronald G. Tompkins; David G. Camp; Richard D. Smith; Henry V. Baker; Paul E. Bankey; Timothy R. Billiar; Bernard H. Brownstein; Steve E. Calvano; Celeste Campbell-Finnerty; George Casella; Irshad H. Chaudry; Mashkoor A. Choudhry; J. Perren Cobb; Asit De; Constance Elson; Bradley D. Freeman; Richard L. Gamelli; Nicole S. Gibran

Although human plasma represents an attractive sample for disease biomarker discovery, the extreme complexity and large dynamic range in protein concentrations present significant challenges for characterization, candidate biomarker discovery, and validation. Herein we describe a strategy that combines immunoaffinity subtraction and subsequent chemical fractionation based on cysteinyl peptide and N-glycopeptide captures with two-dimensional LC-MS/MS to increase the dynamic range of analysis for plasma. Application of this “divide-and-conquer” strategy to trauma patient plasma significantly improved the overall dynamic range of detection and resulted in confident identification of 22,267 unique peptides from four different peptide populations (cysteinyl peptides, non-cysteinyl peptides, N-glycopeptides, and non-glycopeptides) that covered 3654 different proteins with 1494 proteins identified by multiple peptides. Numerous low abundance proteins were identified, exemplified by 78 “classic” cytokines and cytokine receptors and by 136 human cell differentiation molecules. Additionally a total of 2910 different N-glycopeptides that correspond to 662 N-glycoproteins and 1553 N-glycosylation sites were identified. A panel of the proteins identified in this study is known to be involved in inflammation and immune responses. This study established an extensive reference protein database for trauma patients that provides a foundation for future high throughput quantitative plasma proteomic studies designed to elucidate the mechanisms that underlie systemic inflammatory responses.


Critical Care Medicine | 1996

Endothelial cell activity varies in patients at risk for the adult respiratory distress syndrome

Marc Moss; May K. Gillespie; Lynn Ackerson; Fredrick A. Moore; Ernest E. Moore; Polly E. Parsons

OBJECTIVE The endothelial cell produces many bioactive compounds that are presumed to play important roles in the pathogenesis of the adult respiratory distress syndrome (ARDS). We postulated that individuals with sepsis and trauma-two at-risk diagnoses for the development of ARDS--might demonstrate differences in the degree of endothelial cell activity. DESIGN Prospective cohort study. SETTING Intensive care unit patients in a tertiary, university-affiliated, city hospital. PATIENTS Fifty-five intensive care unit patients (19 with sepsis and 36 trauma patients). INTERVENTIONS Plasma measurements of three endothelial cell products--von Willebrand factor antigen, soluble intercellular adhesion molecule-1 (ICAM-1), and soluble E-selectin-were performed within 8 hrs of patients meeting our inclusion criteria, and at the clinical onset of ARDS. MEASUREMENTS AND MAIN RESULTS Twenty-six percent of the septic patients and 25% of the trauma patients developed ARDS. The median (and 25% to 75% quartiles) concentrations of all three mediators measured in the sepsis patients (von Willebrand factor antigen 399% [375% to 452%], ICAM-1 573 ng/mL [470 to 980], and soluble E-selectin 180 ng/mL [81 to 340]) were significantly higher (p < .001 for each individual analysis) than in the trauma patients (von Willebrand factor antigen 256% [217% to 310%], ICAM-1 148 ng/mL [113 to 210], and soluble E-selectin 42 ng/mL [31 to 65 ng/ mL]). In addition, neither the ICAM-1 nor soluble E-selectin concentrations measured in the trauma patients were different (p = .17 and p = .24, respectively) from normal controls. In those patients who developed ARDS, the differences in the concentrations of all three endothelial cell mediators between the sepsis and trauma patients persisted (p = .008 for von Willebrand factor antigen, p = .003 for ICAM-1, and p = .003 for E-selectin). CONCLUSION These findings suggest that differences in endothelial cell activity exist between sepsis and trauma patients who are at risk for the development of ARDS.


Critical Care Medicine | 1996

An increase in serum C18 unsaturated free fatty acids as a predictor of the development of acute respiratory distress syndrome.

Stuart L. Bursten; David Federighi; Polly E. Parsons; Ward E. Harris; Edward Abraham; Ernest E. Moore; Fredrick A. Moore; James A. Bianco; Jack W. Singer; John E. Repine

OBJECTIVE No means exist for predicting the acute respiratory distress syndrome (ARDS), which complicates sepsis, trauma, and a variety of clinical disorders. Because activation of phospholipid-signaling pathways involving the acyl chains oleate and linoleate may initiate and amplify the inflammatory response, and thereby lead to the development of ARDS, we examined whether serum concentrations of these bioactive lipids increase and are predictive of ARDS in at-risk patients. DESIGN Part I: A prospective, single-blind trial. Part II: A prospective, randomized, double-blind trial. SETTING General intensive therapy units in five university teaching hospitals. SUBJECTS Part I: Thirty-nine healthy control patients were studied to determine normal distribution of serum acyl values, followed by 30 patients admitted with onset of sepsis, trauma, or development of ARDS (within 24 hrs of admission) over a 1-yr period. Part II: Eight patients admitted with sepsis syndrome over a 2-month period. INTERVENTIONS Part II: Patients were randomized to receive the substituted methylxanthine, lisofylline (CT1501R), or an identically presented placebo. MEASUREMENTS AND MAIN RESULTS We measured the serum free fatty acid concentrations in the 39 healthy control subjects, and then we prospectively examined the serum free fatty acid concentrations in 30 age-matched patients in samples obtained within 24 hrs from the onset of sepsis, trauma, or development of ARDS. We then prospectively studied eight septic, at-risk patients who were matched for age, Acute Physiology and Chronic Health Evaluation II scores, Multiple Organ Failure index, and Glasgow Coma Score, in a double-blind, placebo-controlled, pilot study. These patients included four patients who received no treatment and four patients who received lisofylline, a compound that decreases serum unsaturated free fatty acids and diminishes acute lung injury in animals caused by sepsis and/or trauma. The calculated ratios of serum free fatty acids (Le., the ratio of C18 unsaturated fatty acids linoleate and oleate to fully saturated palmitate, C16:0) increased and predicted the development of ARDS in at-risk patients. Serum samples from the 30 patients, obtained within 24 hrs from the onset of sepsis, trauma, or development of ARDS, had significantly increased mean acyl chain ratios (1.42 +/- 0.35 [SD]) compared with healthy control subjects (0.86 +/- 0.25; p < .01). Sera from 13 patients with sepsis or trauma who did not develop ARDS (group A [at-risk, non-pre-ARDS]) also had increased acyl ratios (1.23 +/- 0.27) compared with sera from healthy control subjects (0.86 +/- 0.25; p < .01). Sera from seven patients who subsequently developed ARDS (group B [at-risk, pre-ARDS]) had higher acyl ratios (1.70 +/- 0.21) than group A at-risk patients who did not develop ARDS (1.23 +/- 0.27; p < .01) or healthy control subjects (0.86 +/- 0.25; p < .001). Sera from ten group C patients with ARDS at the time of admission to the study had the highest acyl ratios (1.80 +/- 0.75), which exceeded values for healthy control subjects (p < .001) and group A at-risk patients without ARDS (p = .01), but were not significantly different then group B at-risk, pre-ARDS patients (p = .17). Prospective study of eight septic, at-risk patients demonstrated significantly (p < .05) increased serum acyl ratios in the four untreated patients (findings consistent with the first study) but a significantly (p = .02) reduced ratio in the four at-risk patients treated with lisofyline. CONCLUSIONS Increases in unsaturated serum acyl chain ratios differentiate between healthy and seriously iII patients, and identify those patients likely to develop ARDS. Thus, the serum acyl ratio may not only prospectively identify and facilitate the assessment of new treatments in patients at highest risk for developing ARDS, but may also lead to new insights about the pathogenesis of ARDS.


Journal of Trauma-injury Infection and Critical Care | 1992

Balloon tamponade for bilobar transfixing hepatic gunshot wounds.

Renato Sérgio Poggetti; Moore Ee; Fredrick A. Moore; Mitchell Mb; Robert A. Read

The nonresectional approach to major liver trauma is clearly preferred. Unfortunately, trachotomy with vessel ligation, selective hepatic arterial ligation, perihepatic pack, and fibrin glue are not viable options with high-energy bilobar liver injuries. We have fashioned a balloon tamponade device that has proved very effective for these transfixing hepatic gunshot wounds.


World Journal of Emergency Surgery | 2016

2016 WSES guidelines on acute calculous cholecystitis

Luca Ansaloni; Michele Pisano; F. Coccolini; Andrew B Peitzmann; Abe Fingerhut; Fausto Catena; Ferdinando Agresta; A. Allegri; I. Bailey; Zsolt J. Balogh; Cino Bendinelli; Walter L. Biffl; Luigi Bonavina; G. Borzellino; Francesco Brunetti; Clay Cothren Burlew; G. Camapanelli; Fabio Cesare Campanile; Marco Ceresoli; Osvaldo Chiara; Ian Civil; Raul Coimbra; M. De Moya; S. Di Saverio; Gustavo Pereira Fraga; Sanjay Gupta; Jeffry L. Kashuk; M.D. Kelly; V. Koka; Hans Jeekel

Acute calculus cholecystitis is a very common disease with several area of uncertainty. The World Society of Emergency Surgery developed extensive guidelines in order to cover grey areas. The diagnostic criteria, the antimicrobial therapy, the evaluation of associated common bile duct stones, the identification of “high risk” patients, the surgical timing, the type of surgery, and the alternatives to surgery are discussed. Moreover the algorithm is proposed: as soon as diagnosis is made and after the evaluation of choledocholitiasis risk, laparoscopic cholecystectomy should be offered to all patients exception of those with high risk of morbidity or mortality. These Guidelines must be considered as an adjunctive tool for decision but they are not substitute of the clinical judgement for the individual patient.


World Journal of Emergency Surgery | 2013

WSES guidelines for emergency repair of complicated abdominal wall hernias

Massimo Sartelli; Federico Coccolini; Gabrielle H. van Ramshorst; Giampiero Campanelli; Vincenzo Mandalà; Luca Ansaloni; Ernest E. Moore; Andrew B. Peitzman; George C. Velmahos; Fredrick A. Moore; Ari Leppäniemi; Clay Cothren Burlew; Walter L. Biffl; Kaoru Koike; Yoram Kluger; Gustavo Pereira Fraga; Carlos A. Ordoñez; Salomone Di Saverio; Ferdinando Agresta; Boris Sakakushev; Igor Gerych; Imtiaz Wani; Michael D. Kelly; Carlos Augusto Gomes; Mario Paulo Faro; Korhan Taviloglu; Zaza Demetrashvili; Jae Gil Lee; Nereo Vettoretto; Gianluca Guercioni

Emergency repair of complicated abdominal hernias is associated with poor prognosis and a high rate of post-operative complications.A World Society of Emergency Surgery (WSES) Consensus Conference was held in Bergamo in July 2013, during the 2nd Congress of the World Society of Emergency Surgery with the goal of defining recommendations for emergency repair of abdominal wall hernias in adults. This document represents the executive summary of the consensus conference approved by a WSES expert panel.


Archive | 2016

2016 WSES guidelines on acute calculous cholecystitis (vol 11, 25, 2016)

Luca Ansaloni; Michele Pisano; F. Coccolini; Andrew B Peitzmann; Abe Fingerhut; Fausto Catena; Ferdinando Agresta; A. Allegri; I. Bailey; Zsolt J. Balogh; Cino Bendinelli; Walter L. Biffl; Luigi Bonavina; G. Borzellino; Francesco Brunetti; Clay Cothren Burlew; G. Camapanelli; Fabio Cesare Campanile; Marco Ceresoli; Osvaldo Chiara; Ian D. Civil; Raul Coimbra; M. De Moya; S. Di Saverio; Gustavo Pereira Fraga; Sanjay Gupta; Jeffry L. Kashuk; M.D. Kelly; Vladimir Khokha; Hans Jeekel

[This corrects the article DOI: 10.1186/s13017-016-0082-5.].


Journal of Trauma-injury Infection and Critical Care | 2006

Inflammation and the host response to injury, a large-scale collaborative project: Patient-oriented research core-standard operating procedures for clinical care. IV. Guidelines for transfusion in the trauma patient.

Michael A. West; Michael B. Shapiro; Avery B. Nathens; Jeffrey L. Johnson; Ernest E. Moore; Joseph P. Minei; Paul E. Bankey; Brad Freeman; Brian G. Harbrecht; Bruce A. McKinley; Fredrick A. Moore; Ronald V. Maier


Journal of Trauma-injury Infection and Critical Care | 2005

Mortality from Isolated Civilian Penetrating Extremity Injury

Warren C. Dorlac; Michael E. DeBakey; John B. Holcomb; S. P. Fagan; K. L. Kwong; Gina R. Dorlac; Martin A. Schreiber; David Persse; Fredrick A. Moore; Kenneth L. Mattox


Journal of Trauma-injury Infection and Critical Care | 2006

Heart rate variability and its association with mortality in prehospital trauma patients.

William H. Cooke; Jose Salinas; Victor A. Convertino; David A. Ludwig; Denise Hinds; James H. Duke; Fredrick A. Moore; John B. Holcomb

Collaboration


Dive into the Fredrick A. Moore's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ronald V. Maier

Harborview Medical Center

View shared research outputs
Top Co-Authors

Avatar

Avery B. Nathens

Sunnybrook Health Sciences Centre

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Bruce A. McKinley

Houston Methodist Hospital

View shared research outputs
Top Co-Authors

Avatar

Jeffrey L. Johnson

University of Colorado Denver

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Joseph P. Minei

University of Texas Southwestern Medical Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge